Episode Details
Back to Episodes
Aspartame, Sucralose, Saccharin, and Stevia: Comparative Mechanistic Plausibility in Glaucoma
Description
This audio article is from VisualFieldTest.com.
Read the full article here: https://visualfieldtest.com/en/aspartame-sucralose-saccharin-and-stevia-comparative-mechanistic-plausibility-in-glaucoma
Test your visual field online: https://visualfieldtest.com
Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support
Excerpt:
Aspartame, Sucralose, Saccharin, and Stevia: Comparative Mechanistic Plausibility in Glaucoma Introduction People with glaucoma often ask whether diet drinks, artificial sweeteners, or stevia could damage the optic nerve. The question is biologically reasonable because glaucoma is not only an eye-pressure disorder. Retinal ganglion cell injury can also involve vascular dysregulation, impaired endothelial function, oxidative stress, mitochondrial dysfunction, blood-retinal barrier changes, and chronic neuroinflammation. () However, a biologically plausible pathway is not the same as a demonstrated clinical risk. At present, there is no established human evidence that ordinary consumption of aspartame, sucralose, saccharin, or purified steviol glycosides causes glaucoma or accelerates glaucomatous progression. The available evidence is mainly regulatory toxicology, absorption studies, metabolic research, cell experiments, animal studies, and research on cardiovascular or inflammatory outcomes rather than glaucoma itself. Existing glaucoma nutrition reviews do not identify these sweeteners as proven glaucoma risk factors. () The most defensible conclusion is therefore: > For typical intake within established safety limits, all four sweeteners are more likely to be neutral with respect to glaucoma than directly harmful or beneficial. The main potential benefit is indirect: replacing sugar-sweetened foods or beverages may reduce glucose-related vascular stress. The main uncertainty concerns high, chronic intake and individual metabolic or microbiome responses—not a proven direct toxic effect on the optic nerve. How glaucoma physiology relates to sweeteners Glaucoma involves progressive loss of retinal ganglion cells and their optic nerve axons. Elevated intraocular pressure is the most important modifiable risk factor, but some patients continue to lose retinal tissue even when pressure is adequately controlled. This has led to increased interest in blood flow, endothelial function, mitochondrial injury, and immune signaling. () Endothelial function and ocular blood flow The vascular endothelium regulates vessel tone, blood flow, permeability, inflammation, and nitric oxide signaling. Studies of primary open-angle glaucoma have reported systemic vascular abnormalities, including impaired peripheral endothelial function and possible involvement of nitric oxide-related pathways. These observations are particularly relevant to normal-tension glaucoma and other forms in which optic nerve injury occurs at relatively modest eye pressures. () Still, brachial artery flow-mediated dilation is not the same as blood flow at the optic nerve head. A change in systemic vascular function does not automatically cause a change in ocular perfusion, and a laboratory effect on endothelial cells does not establish glaucoma risk. Neuroinflammation and the retinal immune environment The retina contains resident immune cells called microglia, along with astrocytes and Müller cells. Under chronic stress, these cells can release inflammatory mediators such as tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, complement-related proteins, and other signaling molecules. Persistent glial activation may amplify retinal ganglion cell injury. () The blood-retinal barrier normally limits exposure of r